Bill Text: NY A05914 | 2023-2024 | General Assembly | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Designates Xylazine as a schedule III depressant.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-01-03 - referred to health [A05914 Detail]
Download: New_York-2023-A05914-Introduced.html
Bill Title: Designates Xylazine as a schedule III depressant.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-01-03 - referred to health [A05914 Detail]
Download: New_York-2023-A05914-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 5914 2023-2024 Regular Sessions IN ASSEMBLY March 24, 2023 ___________ Introduced by M. of A. WOERNER -- read once and referred to the Commit- tee on Health AN ACT to amend the public health law, in relation to designating Xyla- zine as a schedule III depressant The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision (c) of schedule III of section 3306 of the 2 public health law is amended by adding a new paragraph 15 to read as 3 follows: 4 (15) Xylazine (N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3 thiazin-2- 5 amine). 6 § 2. This act shall take effect on the ninetieth day after it shall 7 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD06914-01-3